SOBI:STO
Swedish Orphan Biovitrum AB (publ)
498,20 SEK
arrow_upward
+0,93%(+4,60) 1D
6-ноя., 17:29:36 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
483,00 SEK
High
498,20 SEK
Low
479,00 SEK
Mkt. cap
178,17 млд
Avg. vol.
341,57 миң
Volume
563,09 миң
P/E ratio
26,46
52-wk high
498,20 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 млн
No. of employees
2 миң
Open
483,00 SEK
High
498,20 SEK
Low
479,00 SEK
Mkt. cap
178,17 млд
Avg. vol.
341,57 миң
Volume
563,09 миң
P/E ratio
26,46
52-wk high
498,20 SEK
52-wk low
314,40 SEK
EPS
18,83 SEK
Shares outstanding
357,64 млн
No. of employees
2 миң
News stories
From web sources and news partners
Finviz
·
1 саат мурун
PSQ Holdings Shrinks Losses And Cash Burn, But Slowing Growth, A Steep Q4 Target And NYSE Listing Risk Define The Setup
Reuters Connect
·
2 саат мурун
Traders work on the floor of the NYSE in New York
Central Oregon Daily
·
12 мүнөт мурун
Nasdaq rebounds but remains on track for fourth straight weekly decline
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)